Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation

Carcinogenesis

Volumn 29, Issue 7, 2008, Pages 1435-1440

  Bi, Xiuli ^a   Tong, Chang ^a   Dockendorff, Ashley ^b   Bancroft, Laura ^b   Gallagher, Lindsay ^a   Guzman, Grace ^a   Iozzo, Renato V ^c   Augenlicht, Leonard H ^b   Yang, Wancai ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ALBERT EINSTEIN CANCER CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DECORIN; INTESTINAL TREFOIL FACTOR; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE LOCATION; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INTESTINE CANCER; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIET; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE SILENCING; HUMANS; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES; PROTEOGLYCANS; SIGNAL TRANSDUCTION;

EID: 49349109705     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn141     Document Type: Article

References (42)

1. Iozzo,R.V. (1999) Matrix proteoglycans: From molecular design to cellular function. Annu. Rev. Biochem., 67, 609-652.
2. Iozzo,R.V. et al. (1999) Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem., 274, 4489-4492.
3. Reed,C.C. et al. (2002) The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj. J., 19, 249-255.
4. Csordas,G. et al. (2000) Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J. Biol. Chem., 275, 32879-32887.
5. Moscatello,D.K. et al. (1998) Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 101, 406-412.
6. Schonherr,E. et al. (2001) Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) hut not p27(KIP1). J. Biol. Chem., 276, 40687-40692.
7. Banerjee,A.G. et al. (2003) Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res., 63, 7769-7776.
8. Reed,C.C. et al. (2002) Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene, 21, 3688-3695.
9. Wick,W. et al. (2006) Transforming growth factor-beta: A molecular target for ihe future therapy of glioblastoma. Curr. Pharm. Des., 12, 341-349.
10. Santra,M. et al. (1995) De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc. Natl Acad. Sci. USA, 92, 7016-7020.
11. De Luca,A. et al. (1996) Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J. Biol. Chem., 271, 18961-18965.
12. Reed,C.C. et al. (2005) Decorin prevents metastatic spreading of breast cancer. Oncogene, 24, 1104-1110.
13. Danielson, K.G. et al. (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol., 136, 729-743.
14. Tong,C. et al. (2007) c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression. Am. J. Pathol. 171, 297-303.
15. Yang,W. et al. (2001) Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res., 61, 565-569.
16. Yang,W. et al. (2003) Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet. Cancer Res. 63, 4990-4996.
17. Fodde,R. et al. (1994) A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl Acad Sci. USA, 91, 8969-8973.
18. Yang,W. et al. (2005) p27kip1 in intestinal tumorigenesis and chemoprevention in the mouse. Cancer Res., 65, 9363-9368.
19. Newmark,H.L. et al. (2001) A Western-style diet induces benign and malignant neoplasms in the colon of normal C57B1/6 mice. Carcinogenesis, 22, 1871-1875.
20. Andrianifahanana,M. et al. (2006) Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim. Biophys. Acta, 1765, 189-222.
21. Velcich,A. et al. (2002) Colorectal cancer in mice genetically deficient in the mucin Muc2. Science, 295, 1726-1729.
22. Iozzo,R.V. et al. (1999) Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc. Natl Acad. Sci. USA, 96, 3092-3097.
23. Harper,J.W. et al. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
24. el-Deiry,W.S. et al. (1995) Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res., 95 2910-2919.
25. Polyak,K. et al. (1996) Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am. J. Pathol., 149 381-387.
26. Nash,M.A. et al. (1999) In vitro growth inhibition of ovarian cancer cells by decorin: Synergism of action between decorin and carboplatin. Cancer Res., 59, 6192-6196.
27. Santa,M. et al. (1997) Isotopic expression of decorin protein core causes a generalized growth suppression in nepplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest., 100, 149-157.
28. Xaus,J. et al. (2001) Decorin inhibits macrophage colony-stimulating factor proliferition of macrophages and enhances cell survival through induction of p27 (Kip1) and p21(Waf1). Blood, 98, 2124-2133.
29. Yang,W. et al. (2005) Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice. Am. J. Pathol., 166 1239-1246.
30. Velcich,A. et al. (1997) Organization and regulatory aspects of the human intestinal mucin gene (MUC2) locus. J. Biol. Chem., 272, 7968-7976.
31. van Minken,B.J. et al. (1999) Gastrointestinal expression and partial cDNA cloning of murine Muc:2. Am. J. Physiol., 276, G115-G124.
32. Sherr,C.J. et al. (1999) CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev., 13, 1501-1512.
33. Cariou,S. et al. (1998) Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1. Breast Cancer Res. Treat. 52, 29-41.
34. Deschenes,C. et al. (2001) Role of p27(Kip1) in human intestinal cell differentiation. Gastroenterology, 120, 423-438.
35. Lloyd,R.V. et al. (1999) p27kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol., 154, 313-323.
36. Thomas,G.V. et al. (1998) Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am. J. Pathol., 153, 681-687.
37. Tsihlias,J. et al. (1999) The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu. Rev. Med. 50, 401-423.
38. Yao,J. et al. (2000) Down-regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas. Int. J. Cancer, 89, 213-216.
39. Zhang,H. et al. (2001) Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer. Int. J. Oncol., 19, 49-52.
40. van de Wetering,M. et al. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-250.
41. Logan,C.Y. et al. (2004) The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol., 20, 781-810.
42. Wheelock,M.J. et al. (2003) Cadherins as modulators of cellular phenotype. Annu. Rev. Cell Dev. Biol., 19, 207-235.